Mental Health Innovation: Why Psychedelic Therapies are Attracting Big Pharma?
Psychedelic therapies are witnessing an exponential surge in the mental health space. This resurgence stems from simplified or relaxed regulatory barriers, shifts in public perception, and the lack of new psychopharmacological options in the psychiatry pipeline. Additionally, rigorous scientific research on psychedelic drugs and evidence of efficacy from clinical trials are also adding to their […]
Redefining Psychiatry: Psychedelic Neurotherapeutics as a Clinical Paradigm Shift
What’s Driving the Renewed Interest in Psychedelic Medicine? The increasing acceptance of psychedelic neuro-therapeutics is changing mental health care while eliminating harm for the most difficult-to-treat malaise of our times: anxiety, depression, addiction, PTSD, etc. Encouraging early results with psychedelics like psilocybin, MDMA, and others have spurred the opening of clinics offering them, and will […]